Prescription of teratogenic medications in United States ambulatory practices

Eleanor Schwarz, Judith Maselli, Mary Norton, Ralph Gonzales

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

PURPOSE: The purpose of this study was to identify the potentially teratogenic medications most frequently prescribed to women of childbearing age and the specialty of physicians who provide ambulatory care to women who use such medications. In addition, we evaluated rates of contraceptive counseling to explore awareness of the risks associated with teratogenic medication use. SUBJECTS AND METHODS: The prescription of teratogenic medications and provision of contraceptive counseling on 12 681 visits made by nonpregnant women, 14 to 44 years of age, to 1880 physicians in US ambulatory practice (National Ambulatory Medical Care Survey) between 1998 and 2000 was analyzed. RESULTS: Use of a potentially teratogenic, class D or X, medication by a woman of childbearing age is documented on 1 of every 13 visits made to US ambulatory practices. These include anxiolytics (4.1 million annual prescriptions), anticonvulsant medications (1.4 million annual prescriptions), antibiotics like doxycycline (1.4 million annual prescriptions), and statins (0.8 million annual prescriptions). Isotretinoin accounts for less than 5% of potentially teratogenic prescriptions (0.5 million annual prescriptions). Internists and family/general practitioners provide ambulatory care to 45% of women prescribed potentially teratogenic medications, psychiatrists provide ambulatory care to 20% of women prescribed potentially teratogenic medications, and dermatologists provide ambulatory care to 20% of women prescribed potentially teratogenic medications. Contraceptive counseling was provided on less than 20% of visits that documented use of a potential teratogen by a woman of childbearing age. Women using low-risk (class A or B) drugs received contraceptive counseling as frequently as women using potential teratogens (P = .24). CONCLUSION: Potentially teratogenic medications are prescribed to millions of women of childbearing age each year. Physician awareness of the teratogenic risk associated with class D or X medications seems low.

Original languageEnglish (US)
Pages (from-to)1240-1249
Number of pages10
JournalAmerican Journal of Medicine
Volume118
Issue number11
DOIs
StatePublished - Nov 1 2005
Externally publishedYes

Fingerprint

Prescriptions
Ambulatory Care
Contraceptive Agents
Counseling
Teratogens
Physicians
Health Care Surveys
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Isotretinoin
Doxycycline
Anti-Anxiety Agents
Anticonvulsants
General Practitioners
Psychiatry
Anti-Bacterial Agents

Keywords

  • Birth defects
  • Contraception
  • National Ambulatory Medical Care Survey (NAMCS)
  • Prescription drug
  • Teratogens

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Prescription of teratogenic medications in United States ambulatory practices. / Schwarz, Eleanor; Maselli, Judith; Norton, Mary; Gonzales, Ralph.

In: American Journal of Medicine, Vol. 118, No. 11, 01.11.2005, p. 1240-1249.

Research output: Contribution to journalArticle

Schwarz, Eleanor ; Maselli, Judith ; Norton, Mary ; Gonzales, Ralph. / Prescription of teratogenic medications in United States ambulatory practices. In: American Journal of Medicine. 2005 ; Vol. 118, No. 11. pp. 1240-1249.
@article{40a9aa9b97cb49fbb4713164ec52d0e1,
title = "Prescription of teratogenic medications in United States ambulatory practices",
abstract = "PURPOSE: The purpose of this study was to identify the potentially teratogenic medications most frequently prescribed to women of childbearing age and the specialty of physicians who provide ambulatory care to women who use such medications. In addition, we evaluated rates of contraceptive counseling to explore awareness of the risks associated with teratogenic medication use. SUBJECTS AND METHODS: The prescription of teratogenic medications and provision of contraceptive counseling on 12 681 visits made by nonpregnant women, 14 to 44 years of age, to 1880 physicians in US ambulatory practice (National Ambulatory Medical Care Survey) between 1998 and 2000 was analyzed. RESULTS: Use of a potentially teratogenic, class D or X, medication by a woman of childbearing age is documented on 1 of every 13 visits made to US ambulatory practices. These include anxiolytics (4.1 million annual prescriptions), anticonvulsant medications (1.4 million annual prescriptions), antibiotics like doxycycline (1.4 million annual prescriptions), and statins (0.8 million annual prescriptions). Isotretinoin accounts for less than 5{\%} of potentially teratogenic prescriptions (0.5 million annual prescriptions). Internists and family/general practitioners provide ambulatory care to 45{\%} of women prescribed potentially teratogenic medications, psychiatrists provide ambulatory care to 20{\%} of women prescribed potentially teratogenic medications, and dermatologists provide ambulatory care to 20{\%} of women prescribed potentially teratogenic medications. Contraceptive counseling was provided on less than 20{\%} of visits that documented use of a potential teratogen by a woman of childbearing age. Women using low-risk (class A or B) drugs received contraceptive counseling as frequently as women using potential teratogens (P = .24). CONCLUSION: Potentially teratogenic medications are prescribed to millions of women of childbearing age each year. Physician awareness of the teratogenic risk associated with class D or X medications seems low.",
keywords = "Birth defects, Contraception, National Ambulatory Medical Care Survey (NAMCS), Prescription drug, Teratogens",
author = "Eleanor Schwarz and Judith Maselli and Mary Norton and Ralph Gonzales",
year = "2005",
month = "11",
day = "1",
doi = "10.1016/j.amjmed.2005.02.029",
language = "English (US)",
volume = "118",
pages = "1240--1249",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - Prescription of teratogenic medications in United States ambulatory practices

AU - Schwarz, Eleanor

AU - Maselli, Judith

AU - Norton, Mary

AU - Gonzales, Ralph

PY - 2005/11/1

Y1 - 2005/11/1

N2 - PURPOSE: The purpose of this study was to identify the potentially teratogenic medications most frequently prescribed to women of childbearing age and the specialty of physicians who provide ambulatory care to women who use such medications. In addition, we evaluated rates of contraceptive counseling to explore awareness of the risks associated with teratogenic medication use. SUBJECTS AND METHODS: The prescription of teratogenic medications and provision of contraceptive counseling on 12 681 visits made by nonpregnant women, 14 to 44 years of age, to 1880 physicians in US ambulatory practice (National Ambulatory Medical Care Survey) between 1998 and 2000 was analyzed. RESULTS: Use of a potentially teratogenic, class D or X, medication by a woman of childbearing age is documented on 1 of every 13 visits made to US ambulatory practices. These include anxiolytics (4.1 million annual prescriptions), anticonvulsant medications (1.4 million annual prescriptions), antibiotics like doxycycline (1.4 million annual prescriptions), and statins (0.8 million annual prescriptions). Isotretinoin accounts for less than 5% of potentially teratogenic prescriptions (0.5 million annual prescriptions). Internists and family/general practitioners provide ambulatory care to 45% of women prescribed potentially teratogenic medications, psychiatrists provide ambulatory care to 20% of women prescribed potentially teratogenic medications, and dermatologists provide ambulatory care to 20% of women prescribed potentially teratogenic medications. Contraceptive counseling was provided on less than 20% of visits that documented use of a potential teratogen by a woman of childbearing age. Women using low-risk (class A or B) drugs received contraceptive counseling as frequently as women using potential teratogens (P = .24). CONCLUSION: Potentially teratogenic medications are prescribed to millions of women of childbearing age each year. Physician awareness of the teratogenic risk associated with class D or X medications seems low.

AB - PURPOSE: The purpose of this study was to identify the potentially teratogenic medications most frequently prescribed to women of childbearing age and the specialty of physicians who provide ambulatory care to women who use such medications. In addition, we evaluated rates of contraceptive counseling to explore awareness of the risks associated with teratogenic medication use. SUBJECTS AND METHODS: The prescription of teratogenic medications and provision of contraceptive counseling on 12 681 visits made by nonpregnant women, 14 to 44 years of age, to 1880 physicians in US ambulatory practice (National Ambulatory Medical Care Survey) between 1998 and 2000 was analyzed. RESULTS: Use of a potentially teratogenic, class D or X, medication by a woman of childbearing age is documented on 1 of every 13 visits made to US ambulatory practices. These include anxiolytics (4.1 million annual prescriptions), anticonvulsant medications (1.4 million annual prescriptions), antibiotics like doxycycline (1.4 million annual prescriptions), and statins (0.8 million annual prescriptions). Isotretinoin accounts for less than 5% of potentially teratogenic prescriptions (0.5 million annual prescriptions). Internists and family/general practitioners provide ambulatory care to 45% of women prescribed potentially teratogenic medications, psychiatrists provide ambulatory care to 20% of women prescribed potentially teratogenic medications, and dermatologists provide ambulatory care to 20% of women prescribed potentially teratogenic medications. Contraceptive counseling was provided on less than 20% of visits that documented use of a potential teratogen by a woman of childbearing age. Women using low-risk (class A or B) drugs received contraceptive counseling as frequently as women using potential teratogens (P = .24). CONCLUSION: Potentially teratogenic medications are prescribed to millions of women of childbearing age each year. Physician awareness of the teratogenic risk associated with class D or X medications seems low.

KW - Birth defects

KW - Contraception

KW - National Ambulatory Medical Care Survey (NAMCS)

KW - Prescription drug

KW - Teratogens

UR - http://www.scopus.com/inward/record.url?scp=27644518176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27644518176&partnerID=8YFLogxK

U2 - 10.1016/j.amjmed.2005.02.029

DO - 10.1016/j.amjmed.2005.02.029

M3 - Article

C2 - 16271908

AN - SCOPUS:27644518176

VL - 118

SP - 1240

EP - 1249

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 11

ER -